Skip to main content
Table of Contents
Print

How do medication changes influence energy swings in ADHD? 

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Changes to ADHD medication, including dose adjustments, switching between drugs, or discontinuation, can significantly affect energy, mood, and daily functioning. According to NHS clinical guidance, these shifts may cause temporary fatigue, irritability, or “energy crashes” as the body adapts to new stimulant or non-stimulant levels. NICE advises that such changes should always be closely monitored, as energy fluctuations can impact sleep, concentration, and overall wellbeing. 

Medication adjustments and energy regulation 

During medication adjustments, some individuals experience withdrawal-type symptoms such as tiredness, vivid dreams, and mood swings. The North East London NHS protocol explains that reducing or pausing stimulant medication may lead to temporary dysphoria or fatigue, while dose increases can relieve cyclical energy dips. Non-stimulants such as atomoxetine can also improve attention and motivation but work more gradually, showing less immediate effect than stimulants. 

Stimulant and non-stimulant differences 

Stimulant medications like methylphenidate or lisdexamfetamine typically improve alertness and energy within hours, but many patients report afternoon “wear-off” effects or tolerance over time. Research from King’s College London shows both stimulants and atomoxetine enhance executive function, though stimulants tend to produce sharper peaks and troughs in energy. Non-stimulants such as guanfacine and clonidine, in contrast, provide steadier regulation but can cause sleepiness or lethargy, particularly early in treatment. 

Timing, tolerance, and formulation effects 

Immediate-release medications are more prone to sharp “energy crashes” when doses wear off, whereas extended-release forms maintain smoother coverage and reduce mood swings throughout the day. Studies highlight that tolerance to stimulants can emerge with prolonged use, contributing to fatigue or reduced focus between doses. Clinicians often address this by adjusting timing, formulation, or adding behavioural strategies to support energy pacing. 

NICE recommendations and supportive care 

According to NICE guidance, clinicians should review medication regularly, monitoring fatigue, sleep, and appetite as part of ongoing ADHD management. When tiredness or low mood persist, NICE recommends considering adjustments in dose or drug type, alongside behavioural and lifestyle interventions. Evidence from PubMed also supports integrating sleep-focused therapy and mindfulness-based approaches, which can improve rest and energy during medication transitions. 

Key takeaway 

Medication changes can temporarily disrupt energy stability in ADHD as the brain adjusts to altered dopamine and norepinephrine levels. Extended-release formulations, careful dose titration, and supportive routines can reduce “crash” effects. Combined with behavioural pacing, nutrition, and consistent sleep, these strategies help balance energy while maintaining the therapeutic benefits of ADHD medication. 

Harriet Winslow, BSc
Harriet Winslow, BSc
Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories